Springer Nature
Browse
13045_2019_834_MOESM1_ESM.docx (20.79 kB)

MOESM1 of First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer

Download (20.79 kB)
journal contribution
posted on 2020-01-17, 09:49 authored by Xingsheng Hu, Xin Zheng, Sheng Yang, Lin Wang, Xuezhi Hao, Xinge Cui, Lieming Ding, Li Mao, Pei Hu, Yuankai Shi
Additional file 1. Exclusion and inclusion criteria

Funding

China National Major Project for New Drug Innovation

History

Usage metrics

    Journal of Hematology & Oncology

    Categories

    Keywords

    C-METTyrosine kinase inhibitor9016-MPhase 1Non-small cell lung cancer (NSCLC)

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC